Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Top honor goes to AAMDSIF Medical Advisor

    ... his leadership in describing the genomic landscape of adult myelodysplastic syndromes (MDS), including identifying critical new roles for ribosomal ...

    Article last updated 08/29/2017 - 7:54am.

  2. New study on SCT therapy for SAA, MDS patients

    ... to treat severe aplastic anemia (AA) or hypoplastic myelodysplastic syndrome (MDS) has begun, and the first patient was given the ... disease, tahalssemia, and other bone marrow failure syndromes, such as aplastic anemia and hypoplastic MDS. Cordin would be ...

    Article last updated 08/22/2017 - 9:41am.

  3. The value of survival gains in myelodysplastic syndromes.

    ... to the introduction of 3 novel therapies for myelodysplastic syndromes (MDS). STUDY DESIGN: Retrospective study of patients ...

    Research Article last updated 02/21/2017 - 11:36am.

  4. Stem and progenitor cell alterations in myelodysplastic syndromes

    ... Recent studies have demonstrated that myelodysplastic syndromes (MDS) arise from a small population of disease initiating ...

    Research Article last updated 02/21/2017 - 10:17am.

  5. Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis

    ... binding protein 1 (SETBP1) mutations in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or chronic ...

    Research Article last updated 02/21/2017 - 10:33am.

  6. Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy

    ... is a key survival prognostic factor in lower-risk myelodysplastic syndromes (MDS). Lenalidomide (LEN) can correct anemia in 25% of ...

    Research Article last updated 02/21/2017 - 9:43am.

  7. Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.

    ... BACKGROUND: In myelodysplastic syndromes , thrombocytopenia is associated with mortality, but ...

    Research Article last updated 02/21/2017 - 9:49am.

  8. Allogeneic Hematopoietic Stem Cell Transplantation is Underutilized in Older Patients with Myelodysplastic Syndromes

    ... transplantation (HCT) is the only curative treatment for myelodysplastic syndrome (MDS). The proportion of MDS patients referred for ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 04/14/2017 - 9:28am.

  9. Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

    ... The myelodysplastic syndromes (MDS) comprise a heterogenous group of myeloid disorders with a ...

    Research Article last updated 02/01/2017 - 9:01am.

  10. MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia

    ... Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders of the elderly that ...

    Research Article last updated 02/01/2017 - 8:14am.